Sporadic inclusion body myositis: variability in prevalence and phenotype and influence of the MHC.
暂无分享,去创建一个
[1] W. Engel,et al. Inclusion-body myositis: muscle-fiber molecular pathology and possible pathogenic significance of its similarity to Alzheimer’s and Parkinson’s disease brains , 2008, Acta Neuropathologica.
[2] Ian James,et al. Sporadic inclusion body myositis: HLA-DRB1 allele interactions influence disease risk and clinical phenotype , 2009, Neuromuscular Disorders.
[3] C. Witt,et al. Mapping of a candidate region for susceptibility to inclusion body myositis in the human major histocompatibility complex , 1999, Immunogenetics.
[4] F. Mastaglia,et al. Two major histocompatibility complex haplotypes influence susceptibility to sporadic inclusion body myositis: critical evaluation of an association with HLA-DR3. , 2004, Tissue antigens.
[5] Allan D. Kirk,et al. Effect of Alemtuzumab (CAMPATH 1-H) in patients with inclusion-body myositis , 2009, Brain : a journal of neurology.
[6] F L Mastaglia,et al. Sporadic inclusion body myositis: Phenotypic variability and influence of HLA-DR3 in a cohort of 57 Australian cases , 2008, Journal of Neurology, Neurosurgery, and Psychiatry.
[7] M. Dalakas,et al. Sporadic inclusion body myositis—diagnosis, pathogenesis and therapeutic strategies , 2006, Nature Clinical Practice Neurology.
[8] M. Dalakas,et al. Interrelation of inflammation and APP in sIBM: IL-1β induces accumulation of β-amyloid in skeletal muscle , 2008, Brain : a journal of neurology.
[9] F. Christiansen,et al. The genetic basis for the association of the 8.1 ancestral haplotype (A1, B8, DR3) with multiple immunopathological diseases , 1999, Immunological reviews.
[10] F. Mastaglia,et al. Sporadic inclusion body myositis in Japanese is associated with the MHC ancestral haplotype 52.1 , 2006, Neuromuscular Disorders.
[11] R. Lovelace,et al. Inclusion body myositis mimicking motor neuron disease. , 2001, Archives of neurology.
[12] S. Greenberg. Proposed immunologic models of the inflammatory myopathies and potential therapeutic implications , 2007, Neurology.
[13] Timothy Day,et al. Prevalence of sporadic inclusion body myositis and factors contributing to delayed diagnosis , 2008, Journal of Clinical Neuroscience.
[14] F L Mastaglia,et al. Patterns of muscle involvement in inclusion body myositis: Clinical and magnetic resonance imaging study , 2001, Muscle & nerve.
[15] S. Khadilkar,et al. Study of idiopathic inflammatory myopathies with special reference to borderland between idiopathic inflammatory myopathies and muscular dystrophies. , 2008, Neurology India.
[16] F L Mastaglia,et al. Genetics of inclusion‐body myositis , 2007, Muscle & nerve.
[17] M. Carrington,et al. Immunogenetic Risk and Protective Factors for the Idiopathic Inflammatory Myopathies: Distinct HLA-A, -B, -Cw, -DRB1 and -DQA1 Allelic Profiles and Motifs Define Clinicopathologic Groups in Caucasians , 2005, Medicine.
[18] S. Dimauro,et al. Inclusion body myositis and myopathies , 1995, Annals of neurology.
[19] Susan Walters,et al. Familial inclusion body myositis in a mother and son with different ancestral MHC haplotypes , 2006, Neuromuscular Disorders.
[20] F. Mastaglia,et al. Sporadic inclusion body myositis: a continuing puzzle , 2008, Neuromuscular Disorders.